BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, July 19, 2025
See today's BioWorld Asia
See today's BioWorld
Home
» Torrent Pharma to buy JB Pharma from KKR in $3B M&A deal
To read the full article
sign up for free
or
sign in
.
Torrent Pharma to buy JB Pharma from KKR in $3B M&A deal
July 1, 2025
By
Marian (YoonJee) Chu
No Comments
Torrent Pharmaceutical Ltd. will buy J. B. Chemicals and Pharmaceuticals Ltd. (JB Pharma) from private equity firm KKR & Co. Inc. at an equity valuation of ₹256.89 billion (US$3 billion), which will then merge into one entity under Torrent Pharma.
BioWorld
BioWorld Asia
Deals and M&A
Cardiovascular
Gastrointestinal
Ocular
Asia-Pacific
